Human Vaccines
Volume 6, Issue 6  June 2010
http://www.landesbioscience.com/journals/vaccines/toc/volume/6/issue/6/

News
Malaria Vectored Vaccines Consortium (MVVC)
Sharmila Bakshi and Egeruan Babatunde Imoukhuede

The European Vaccine Initiative (EVI) is coordinating the Malaria Vectored Vaccines Consortium (MVVC), a four year project set-up with the aim of integrating capacity-building and networking in the design and conduct of Phase I and II clinical trials of viral vectored candidate malaria vaccines in East and West African adults, children, and infants. The overall objective of the project is to develop a safe, non-reactogenic, effective, and affordable malaria vaccine for use by the malaria endemic populations of the world.

The MVVC Consortium consists of eight partners; European Vaccine Initiative (EVI); UniversitätsKlinikum Heidelberg, Germany; The University of Oxford (UOXF), United Kingdom (UK); Vienna School of Clinical Research (VSCR), Austria; Okairos s.r.l, Italy; Centre National de Recherche et Formation sur le Paludisme (CNRFP), Burkina Faso; Kenya Medical Research Institute (KEMRI ), Kenya; Medical Research Council Gambia (MRC Gambia), The Gambia; and Université Cheikh Anta Diop (UCAD), Senegal.